BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26232270)

  • 1. Carboplatin therapeutic monitoring in preterm and full-term neonates.
    Veal GJ; Errington J; Hayden J; Hobin D; Murphy D; Dommett RM; Tweddle DA; Jenkinson H; Picton S
    Eur J Cancer; 2015 Sep; 51(14):2022-30. PubMed ID: 26232270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma.
    Picton SV; Keeble J; Holden V; Errington J; Boddy AV; Veal GJ
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):749-52. PubMed ID: 18607591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens.
    Veal GJ; Errington J; Sastry J; Chisholm J; Brock P; Morgenstern D; Pritchard-Jones K; Chowdhury T
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):685-92. PubMed ID: 26875154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours.
    Veal GJ; Errington J; Tilby MJ; Pearson AD; Foot AB; McDowell H; Ellershaw C; Pizer B; Nowell GM; Pearson DG; Boddy AV;
    Br J Cancer; 2007 Mar; 96(5):725-31. PubMed ID: 17299395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.
    Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Duffaud F; Digue L; Tranchand B; Monjanel-Mouterde S; Guillet P; Nicoara A; Baciuchka M; Bagarry-Liegey D; Lacarelle B; Noble A; Durand A; Favre R
    Ther Drug Monit; 2006 Apr; 28(2):212-8. PubMed ID: 16628133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group Trial.
    Thomas H; Boddy AV; English MW; Hobson R; Imeson J; Lewis I; Morland B; Pearson AD; Pinkerton R; Price L; Stevens M; Newell DR
    J Clin Oncol; 2000 Nov; 18(21):3614-21. PubMed ID: 11054434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy.
    Veal GJ; English MW; Grundy RG; Shakespeare C; Glaser A; Waters F; Holden V; O'Meara A; Michalski A; Howe K; Cole S; Boddy AV
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):295-300. PubMed ID: 15133627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
    Duong JK; Veal GJ; Nath CE; Shaw PJ; Errington J; Ladenstein R; Boddy AV
    Br J Clin Pharmacol; 2019 Jan; 85(1):136-146. PubMed ID: 30261554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant.
    Colby C; Koziol S; McAfee SL; Yeap B; Spitzer TR
    Bone Marrow Transplant; 2002 Mar; 29(6):467-72. PubMed ID: 11960264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and individual dose adjustment of carboplatin].
    Chatelut E; Canal P; Bugat R
    Bull Cancer; 2000 Aug; 87 Spec No():17-23. PubMed ID: 11082718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy.
    Rubie H; Doz F; Vassal G; Chastagner P; Gentet JC; Urien S; Bastian G; Drouard-Troalen L; Barberi-Heyob M; Catalin J; Chatelut E;
    Eur J Cancer; 2003 Jul; 39(10):1433-8. PubMed ID: 12826047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dose individualization for carboplatin in cancer chemotherapy].
    Oudard S; Lauraine EP
    Bull Cancer; 1997 Jun; 84(6):675-7. PubMed ID: 9295872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels.
    Ghazal-Aswad S; Tilby MJ; Lind M; Baily N; Sinha DP; Calvert AH; Newell DR
    Ann Oncol; 1999 Mar; 10(3):329-34. PubMed ID: 10355578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carboplatin in pediatrics].
    Doz F
    Bull Cancer; 2000 Aug; 87 Spec No():25-9. PubMed ID: 11082719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two methods for carboplatin dosing in children with retinoblastoma.
    Allen S; Wilson MW; Watkins A; Billups C; Qaddoumi I; Haik BH; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2010 Jul; 55(1):47-54. PubMed ID: 20486170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study.
    Moeung S; Chevreau C; Broutin S; Guitton J; Lelièvre B; Ciccolini J; Massart C; Fléchon A; Delva R; Gravis G; Lotz JP; Bay JO; Gross-Goupil M; Paci A; Marsili S; Malard L; Chatelut E; Thomas F
    Clin Cancer Res; 2017 Dec; 23(23):7171-7179. PubMed ID: 28928162
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors.
    Bailey DB; Rassnick KM; Dykes NL; Pendyala L
    Am J Vet Res; 2009 Jun; 70(6):770-6. PubMed ID: 19496668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.